Impact of diabetes mellitus on mortality in patients with acute heart failure: a prospective cohort study.

Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840 (Electronic) Linking ISSN: 14752840 NLM ISO Abbreviation: Cardiovasc Diabetol Subsets: MEDLINE

Original Publication: London : BioMed Central, [2002-

Diabetes Mellitus/*mortality ; Heart Failure/*mortality; Acute Disease ; Aged ; Aged, 80 and over ; Biomarkers/blood ; Blood Glucose/drug effects ; Blood Glucose/metabolism ; Diabetes Mellitus/blood ; Diabetes Mellitus/diagnosis ; Diabetes Mellitus/drug therapy ; Female ; Glycated Hemoglobin/metabolism ; Heart Failure/diagnosis ; Heart Failure/physiopathology ; Heart Failure/therapy ; Hospital Mortality ; Humans ; Hypoglycemic Agents/therapeutic use ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Registries ; Republic of Korea/epidemiology ; Risk Assessment ; Risk Factors ; Stroke Volume ; Time Factors ; Ventricular Function, Left

Background: Although more than one-third of the patients with acute heart failure (AHF) have diabetes mellitus (DM), it is unclear if DM has an adverse impact on clinical outcomes. This study compared the outcomes in patients hospitalized for AHF stratified by DM and left ventricular ejection fraction (LVEF).
Methods: The Korean Acute Heart Failure registry prospectively enrolled and followed 5625 patients from March 2011 to February 2019. The primary endpoints were in-hospital and overall all-cause mortality. We evaluated the impact of DM on these endpoints according to HF subtypes and glycemic control.
Results: During a median follow-up of 3.5 years, there were 235 (4.4%) in-hospital mortalities and 2500 (46.3%) overall mortalities. DM was significantly associated with increased overall mortality after adjusting for potential confounders (adjusted hazard ratio [HR] 1.11, 95% confidence interval [CI] 1.03-1.22). In the subgroup analysis, DM was associated with higher a risk of overall mortality in heart failure with reduced ejection fraction (HFrEF) only (adjusted HR 1.14, 95% CI 1.02-1.27). Inadequate glycemic control (HbA1c ≥ 7.0% within 1 year after discharge) was significantly associated with a higher risk of overall mortality compared with adequate glycemic control (HbA1c < 7.0%) (44.0% vs. 36.8%, log-rank p = 0.016).
Conclusions: DM is associated with a higher risk of overall mortality in AHF, especially HFrEF. Well-controlled diabetes (HbA1c < 7.0%) is associated with a lower risk of overall mortality compared to uncontrolled diabetes. Trial registration ClinicalTrial.gov, NCT01389843. Registered July 6, 2011. https://clinicaltrials.gov/ct2/show/NCT01389843.

J Am Coll Cardiol. 2004 Mar 3;43(5):771-7. (PMID: 14998615)
J Am Coll Cardiol. 2013 Mar 26;61(12):1259-67. (PMID: 23500328)
J Am Coll Cardiol. 2014 Apr 1;63(12):1123-1133. (PMID: 24491689)
Nutr Metab Cardiovasc Dis. 2018 Nov;28(11):1081-1091. (PMID: 30318112)
JACC Heart Fail. 2017 Nov;5(11):763-771. (PMID: 29032140)
Circ Heart Fail. 2014 Jan;7(1):76-87. (PMID: 24281134)
Eur Heart J. 2008 Jun;29(11):1377-85. (PMID: 18413309)
Circ Heart Fail. 2008 Nov;1(4):234-41. (PMID: 19808297)
Am Heart J. 2014 Nov;168(5):721-30. (PMID: 25440801)
J Am Coll Cardiol. 2007 Aug 21;50(8):768-77. (PMID: 17707182)
Cardiovasc Diabetol. 2019 Jul 5;18(1):86. (PMID: 31277657)
Diabetes Care. 2004 Aug;27(8):1879-84. (PMID: 15277411)
N Engl J Med. 2006 Jul 20;355(3):260-9. (PMID: 16855266)
J Am Coll Cardiol. 2013 Jan 29;61(4):391-403. (PMID: 23219302)
Cardiovasc Diabetol. 2019 Sep 3;18(1):116. (PMID: 31481069)
Int J Cardiol. 2016 Jan 15;203:587-93. (PMID: 26574932)
Circulation. 2017 Mar 7;135(10):e146-e603. (PMID: 28122885)
Circulation. 2011 Sep 6;124(10):1151-9. (PMID: 21844073)
J Clin Invest. 2010 May;120(5):1506-14. (PMID: 20407209)
J Am Coll Cardiol. 2013 Feb 26;61(8):820-9. (PMID: 23333145)
Cell Metab. 2012 May 2;15(5):635-45. (PMID: 22560216)
Eur Heart J. 2006 Nov;27(22):2725-36. (PMID: 17000631)
Eur J Heart Fail. 2017 Oct;19(10):1258-1269. (PMID: 28370829)
Eur Heart J. 2016 Jul 14;37(27):2129-2200. (PMID: 27206819)
Eur J Heart Fail. 2014 Jan;16(1):103-11. (PMID: 24453099)
JACC Heart Fail. 2015 Feb;3(2):136-45. (PMID: 25660838)
Rev Esp Cardiol (Engl Ed). 2019 Oct 16;:. (PMID: 31629690)
Circulation. 2009 Apr 14;119(14):1899-907. (PMID: 19332465)
Eur Heart J. 2014 Mar;35(10):657-64. (PMID: 23756336)
Am Heart J. 2007 Aug;154(2):277.e1-8. (PMID: 17643576)
Int J Cardiol. 2012 May 17;157(1):108-13. (PMID: 22178056)
Circulation. 2017 Feb 21;135(8):724-735. (PMID: 28052977)
Eur J Heart Fail. 2017 Dec;19(12):1586-1596. (PMID: 28295985)
Cardiovasc Diabetol. 2003 Jan 08;2:1. (PMID: 12556246)
Korean Circ J. 2017 May;47(3):341-353. (PMID: 28567084)
JACC Heart Fail. 2020 Mar;8(3):234-242. (PMID: 32035890)
Eur J Heart Fail. 2017 Jan;19(1):54-65. (PMID: 27790816)
Cardiovasc Diabetol. 2019 Apr 8;18(1):47. (PMID: 30961600)
Eur J Heart Fail. 2013 Feb;15(2):194-202. (PMID: 23059198)
Eur Heart J. 2004 Apr;25(8):656-62. (PMID: 15084370)
Eur J Heart Fail. 2014 Jun;16(6):700-8. (PMID: 24797348)

Keywords: Acute heart failure; Diabetes mellitus; Glycemic control; Left ventricular ejection fraction

ClinicalTrials.gov NCT01389843

0 (Biomarkers)
0 (Blood Glucose)
0 (Glycated Hemoglobin A)
0 (Hypoglycemic Agents)
0 (hemoglobin A1c protein, human)

Date Created: 20200504 Date Completed: 20200825 Latest Revision: 20221207

20240105

PMC7196232

10.1186/s12933-020-01026-3

32359358